Organigram Finalizes $10 Million Strategic Investment to Develop Cannabinoids from Yeast

New Cannabis Ventures
By NCV NewswireSep 13, 2018, 6:36 am339 pts
Organigram invests in Hyasynth Biologicals Inc., helps bring transformative “cellular agriculture” to Canadian cannabis industry Investment solidifies Organigram’s commitment to next generation delivery of cannabinoid products to global medical and adult recreational cannabis markets MONCTON, NB, Sept.…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Anti-Marijuana Groups Narc On D.C. Dispensaries In Letter To Trump, Saying They Are Too Close To Schools 80

Cannabis Rescheduling: Myths Versus Reality 73

TILT Holdings Sells 2 Massachusetts Dispensaries to In Good Health 70

PharmaCann Opens 4th Ohio Verilife Dispensary in Solon 70

Scathing audit of Mass. marijuana regulator finds ‘favoritism,’ lost revenue 70

Cannabis Seed Oil Has ‘Superior Effectiveness’ In Healing Wounds Compared To Conventional Antibiotics, Study Shows 69

Last Week in Weed: August 12- 19, 2025 67

Canada’s regulated cannabis market has largely overtaken the illicit sector: report 59

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.